What are the drawbacks of GLP-1s
Trends Pharmacopsychiatry 28, 9099
Energy Expenditure Studies Researchers have investigated whether 5-Amino-1MQ and NNMT inhibition affect energy expenditure and metabolic rate
According to the Mayo Clinic, you may feel faint, woozy, weak, wobbly, or that your surroundings are spinning or otherwise unstable
GLP-1RAs and clinical trials in NAFLD Lixisenatide In a systematic meta-analysis including 12 randomized controlled trials (RCTs) comparing lixisenatide to placebo or active interventions in T2D, lixisenatide was reported to normalize levels of alanine aminotransferase (ALT) in a greater proportion of overweight and obese patients with T2D than comparators (54)
Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by healthcare providers without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturers product information, and comparison with recommendations of other authorities